Want to see HK:3839 full AI Analyst Report?

Chia Tai Enterprises International (3839) Price & Analysis

0 Followers

3839 Stock Chart & Stats

HK$8.44

HK$0.04(0.45%)

At close: Jul 27 4:00 PM EDT

HK$8.44

HK$0.04(0.45%)

Day’s Range― - ―

52-Week RangeHK$5.50 - HK$9.89

Previous CloseN/A

Volume13.50K

Average Volume (3M)63.80K

Market Cap

HK$1.98B

Enterprise ValueHK$2.75B

Total Cash (Recent Filing)HK$37.25M

Total Debt (Recent Filing)HK$75.56M

Price to Earnings (P/E)10.3

Beta1.07

Next Earnings

Nov 05, 2026

EPS EstimateN/A

Next Dividend Ex-DateN/A

Dividend YieldN/A

Share Statistics

EPS (TTM)0.10

Shares Outstanding240,718,300

10 Day Avg. Volume69,280

30 Day Avg. Volume63,804

Financial Highlights & Ratios

PEG Ratio0.04

Price to Book (P/B)0.85

Price to Sales (P/S)0.44

P/FCF Ratio8.42

Enterprise Value/Market CapN/A

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/EbitdaN/A

Forecast

1Y Price TargetN/A

Price Target UpsideN/A

Rating ConsensusN/A

Number of Analyst Covering0

EPS Forecast (FY)N/A

Revenue Forecast (FY)N/A

Bulls Say, Bears Say

Bulls Say

2025 Revenue And Profit ReboundThe sharp 2025 revenue rebound, alongside stronger net and operating margins, indicates improved business activity and operating execution. If this recovery persists, it can rebuild earnings capacity, support reinvestment in the animal-health platform, and strengthen the company’s competitive position over the next several quarters.

Conservative Improving LeverageDeclining leverage and a larger equity base provide greater resilience when operating conditions fluctuate. The improved return on equity also suggests better use of shareholder capital, while lower debt exposure can preserve financial flexibility for investment, working-capital needs, and strategic growth.

Improved Free Cash FlowPositive operating and free cash flow in 2025 provides evidence that reported earnings were translating into cash more effectively than in weaker periods. This improves the company’s ability to fund operations internally, support investment, and reduce dependence on additional borrowing.

Bears Say

Gross Margin CompressionThe materially lower gross margin shows that the recent revenue recovery has not restored earlier levels of profitability. Persistent pricing or cost pressure could limit the earnings benefit of future sales growth, reduce funds available for reinvestment, and make operating results more sensitive to product mix and execution.

Volatile Earnings HistoryA history that includes a loss year and substantial margin variation indicates that earnings power has not yet demonstrated consistent durability. This volatility raises the risk that the latest improvement reflects a cyclical recovery rather than a fully established profit base, complicating long-term planning and capital allocation.

Uneven Historical Cash GenerationAlthough cash generation improved in 2025, repeated historical deficits show that profits have not consistently converted into available cash. Continued working-capital or reinvestment demands could therefore pressure liquidity, constrain internally funded expansion, and weaken financial flexibility if operating performance softens.

Chia Tai Enterprises International News

CPBIO Sets November Board Meeting to Approve Nine-Month Unaudited Results

Chia Tai Enterprises International ( ($HK:3839) ) has provided an announcement. CPBIO Holding Company Limited has scheduled a...

10h ago

CPBIO Calls Special Meeting to Approve HOEL Supply Agreement Caps

Chia Tai Enterprises International ( ($HK:3839) ) has issued an announcement. CPBIO Holding Company Limited has called a...

17d ago

CPBIO renews HOEL supply deal and inks new CPF India agreement as connected transactions

Chia Tai Enterprises International ( ($HK:3839) ) has shared an announcement. CPBIO Holding Company Limited has entered into...

3M ago

CPBIO posts lower interim profit as revenue drops in first half of 2026

Chia Tai Enterprises International ( ($HK:3839) ) has shared an announcement. CPBIO Holding Company Limited reported unaudited revenue...

3M ago

CPBIO Sets August Board Meeting to Approve Interim Results and Consider Dividend

Chia Tai Enterprises International ( ($HK:3839) ) has issued an update. CPBIO Holding Company Limited has scheduled a...

3M ago

CPBIO warns of sharply lower first-half profit as China animal farming slows

An update from Chia Tai Enterprises International ( ($HK:3839) ) is now available. CPBIO Holding Company Limited has...

3M ago

CPBIO Holding Company Launches Comprehensive Rebrand on Hong Kong Listing

Chia Tai Enterprises International ( ($HK:3839) ) has shared an announcement. CPBIO Holding Company Limited has formally changed...

3M ago

Chia Tai Enterprises Wins Full Shareholder Backing at AGM, Approves Name Change and Capital Mandates

Chia Tai Enterprises International ( ($HK:3839) ) has issued an announcement. Chia Tai Enterprises International Limited secured strong...

5M ago

Chia Tai Enterprises’ Q1 Profit Declines on Revenue Drop but Comprehensive Income Holds Up

The latest update is out from Chia Tai Enterprises International ( ($HK:3839) ). Chia Tai Enterprises International reported...

6M ago

Chia Tai Enterprises Sets 2026 AGM to Approve Accounts, Board Mandates and Share Issuance Authority

Chia Tai Enterprises International ( ($HK:3839) ) just unveiled an announcement. Chia Tai Enterprises International has called its...

6M ago

3839 FAQ

What was Chia Tai Enterprises International Limited’s price range in the past 12 months?

Chia Tai Enterprises International Limited lowest stock price was HK$5.50 and its highest was HK$9.89 in the past 12 months.

What is Chia Tai Enterprises International Limited’s market cap?

Chia Tai Enterprises International Limited’s market cap is HK$1.98B.

When is Chia Tai Enterprises International Limited’s upcoming earnings report date?

Chia Tai Enterprises International Limited’s upcoming earnings report date is Nov 05, 2026 which is in 6 days.

How were Chia Tai Enterprises International Limited’s earnings last quarter?

Chia Tai Enterprises International Limited released its earnings results on Aug 11, 2026. The company reported HK$0.117 earnings per share for the quarter.

Is Chia Tai Enterprises International Limited overvalued?

According to Wall Street analysts Chia Tai Enterprises International Limited’s price is currently Overvalued. Get more investment ideas with TipRanks Premium

Does Chia Tai Enterprises International Limited pay dividends?

Chia Tai Enterprises International Limited does not currently pay dividends.

What is Chia Tai Enterprises International Limited’s EPS estimate?

Chia Tai Enterprises International Limited’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does Chia Tai Enterprises International Limited have?

Chia Tai Enterprises International Limited has 240,718,300 shares outstanding.

What happened to Chia Tai Enterprises International Limited’s price movement after its last earnings report?

Chia Tai Enterprises International Limited reported an EPS of HK$0.117 in its last earnings report. Following the earnings report the stock price went down -1.379%.

Which hedge fund is a major shareholder of Chia Tai Enterprises International Limited?

Currently, no hedge funds are holding shares in HK:3839

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

Company Description

Chia Tai Enterprises International Limited

Chia Tai Enterprises International Limited primarily produces and distributes chlortetracycline (CTC) and related goods. Its extensive international reach covers Mainland China, the Asia Pacific region, the Americas, and Europe. The company's operations are divided into two distinct divisions: Biochemical and Industrial. The Biochemical division focuses on the manufacturing and supply of CTC premix and CTC hydrochloride products. These are employed as feed supplements to encourage livestock growth, prevent or cure animal illnesses, and improve feed conversion, sold under the brands Shihao and Citifac. Conversely, the Industrial segment handles the sales, rental, and maintenance of heavy construction machinery, encompassing items such as excavators, power generators, bulldozers, compactors, and their spare parts. This division also fabricates and markets carburetors and other automotive components for various automobile and motorcycle manufacturers. Founded in 1987, the company maintains its headquarters in Central, Hong Kong, and functions as a subsidiary of Charoen Pokphand Foods Public Company Limited.